streptococcu
pneumonia
major
caus
pneumonia
sepsi
mening
poreform
toxin
pneumolysin
key
virul
factor
pneumonia
sens
inflammasom
among
serotyp
serotyp
pneumococci
particularli
emerg
across
globe
major
caus
invas
diseas
caus
particular
howev
incomplet
understood
therefor
examin
pneumococc
infect
human
cell
human
lung
organ
cultur
system
mimick
infect
lower
respiratori
tract
demonstr
differ
pneumococc
serotyp
differenti
activ
inflammasomedepend
product
human
lung
tissu
cell
wherea
serotyp
pneumococci
express
fulli
haemolyt
pneumolysin
activ
inflammasomedepend
respons
serotyp
strain
express
nonhaemolyt
toxin
poor
activ
product
accordingli
purifi
haemolyt
pneumolysin
serotyp
nonhaemolyt
toxin
activ
strong
product
human
lung
data
suggest
evas
inflammasomedepend
innat
immun
respons
serotyp
pneumococci
might
contribut
abil
caus
invas
diseas
human
streptococcu
pneumonia
frequent
colon
human
nasopharynx
major
caus
invas
diseas
depend
preced
viral
infect
immun
statu
host
pneumococc
strain
asymptomat
colon
establish
progress
pneumonia
sepsi
mening
infect
associ
high
morbid
mortal
estim
pneumonia
caus
million
infant
death
everi
year
worldwid
probabl
even
elderli
peopl
immunocompromis
patient
capsular
serotyp
pneumonia
vari
markedli
abil
caus
invas
infect
exampl
serotyp
other
associ
nasopharyng
colon
also
infect
patient
underli
diseas
higher
mortal
caus
pneumonia
contrast
domin
clone
serotyp
frequent
found
invas
diseas
howev
show
lower
casefat
rate
among
serotyp
pneumococci
recent
emerg
clone
domin
mani
part
world
degre
encapsul
posit
associ
colon
preval
virul
bacteri
factor
affect
interact
innat
immun
system
might
also
play
role
addit
capsul
pneumolysin
pli
major
virul
factor
pneumonia
pli
member
cholesteroldepend
cytolysin
express
variou
gramposit
bacteria
pli
pneumococci
bind
cholesterolcontain
membran
form
pore
upon
oligomer
therebi
caus
cell
lysi
sublyt
concentr
pli
describ
activ
complement
system
stimul
cytokin
product
monocyt
macrophag
moreov
pli
implic
biofilm
format
independ
haemolyt
activ
studi
mous
model
primari
pneumococc
pneumonia
demonstr
plydefici
strain
rapidli
clear
lung
induc
less
inflamm
compar
isogen
toxinproduc
bacteria
interestingli
pli
exist
least
differ
protein
variant
variabl
haemolyt
activ
exampl
allel
pli
express
serotyp
serotyp
pneumococci
nonhaemolyt
contrast
allel
pli
strain
recent
studi
us
other
show
innat
immun
system
sens
haemolyt
pli
canon
inflammasom
canon
inflammasom
multiprotein
complex
mainli
express
monocyt
macrophag
compos
receptor
molecul
belong
nodlik
receptor
famili
pyhin
protein
famili
eg
adapt
molecul
asc
inflammasom
posttranscript
regul
product
process
cytokin
proform
matur
cytokin
induc
inflammatori
cell
death
call
pyroptosi
mice
lack
inflammasom
compon
receptor
show
alter
suscept
toward
pneumonia
indic
inflammasom
critic
compon
innat
defenc
system
pneumococc
infect
demonstr
differ
pneumococc
strain
differenti
recogn
innat
immun
system
human
lung
tissu
inflammasom
sens
pneumonia
express
haemolyt
pli
human
lung
tissu
wherea
pneumococc
serotyp
express
nonhaemolyt
toxin
poor
inflammasom
activ
pneumonia
serotyp
describ
pneumonia
serotyp
multi
locu
sequenc
type
mlst
serotyp
serotyp
serotyp
serotyp
kindli
provid
nation
refer
centr
streptococci
germani
bacteria
grown
thi
media
co
reach
phase
logarithm
growth
pli
gene
amplifi
pcr
appropri
strain
clone
novagen
result
addit
polyhi
tag
nterminu
protein
result
construct
transform
e
coli
express
follow
manufactur
instruct
cell
extract
prepar
sonic
cell
pellet
follow
clarif
centrifug
pli
purifi
metal
affin
purif
histag
protein
follow
manufactur
instruct
puriti
confirm
coomassi
blue
stain
protein
separ
sdspage
human
pbmc
purifi
buffi
coat
gradient
centrifug
describ
previous
cell
infect
x
moi
x
moi
cfuml
pneumonia
treat
zyvad
merck
millipor
allel
allel
pli
lung
tissu
sampl
obtain
patient
primarili
suffer
bronchial
carcinoma
underw
lung
resect
local
thorac
surgeri
prepar
describ
previous
written
inform
consent
approv
patient
studi
approv
ethic
committe
clinic
protocol
number
infect
tumorfre
normal
lung
tissu
inject
pneumonia
cfuml
per
tissu
hour
treat
glybenclamid
sigmaaldrich
st
loui
mo
usa
h
infect
releas
quantifi
elisa
cellfre
tissuefre
supernat
ebiosci
bd
bioscienc
lactat
dehydrogenas
ldh
releas
quantifi
cytotox
nonradioact
cytotox
assay
promega
analysi
transcript
regul
total
cellular
rna
isol
transcrib
cdna
amplifi
quantit
rtpcr
use
gene
express
master
mix
taqman
gene
express
assay
appli
biosystem
bacteria
lyse
h
mgml
lysozym
sigmaaldrich
mm
trishcl
mm
nacl
proteas
inhibitor
cocktail
roch
follow
sonic
cellular
fraction
human
blood
pbswash
dilut
pb
incub
pneumococc
lysat
h
room
temperatur
centrifug
red
blood
cell
lysi
assess
highest
amount
pneumococc
lysat
use
gener
cfu
pneumonia
adjac
well
row
repres
dilut
protein
human
lung
tissu
extract
use
lysi
buffer
disrupt
homogen
actin
santa
cruz
biotechnolog
adipogen
antibodi
use
protein
detect
incub
hrpconjug
igg
antibodi
santa
cruz
biotechnolog
pierc
ecl
western
blot
substrat
thermo
scientif
threedimension
protein
structur
allel
pli
built
compar
model
use
model
softwar
crystal
structur
perfringolysin
pdb
use
templat
model
pneumonia
serotyp
genom
sequenc
describ
use
illumina
miseq
next
gener
sequenc
system
chromosom
dna
isol
use
purelink
genom
dna
mini
kit
life
technolog
nextera
xt
pairedend
librari
prepar
sequenc
miseq
use
chemistri
accord
protocol
recommend
manufactur
illumina
sequenc
read
assembl
use
spade
contig
order
use
pneumonia
genom
access
number
refer
genom
draft
genom
sequenc
submit
gendb
annot
system
final
pneumolysin
dna
sequenc
pneumonia
serotyp
provid
gendb
wherea
draft
genom
sequenc
read
use
compar
genom
analysi
data
express
mean
sem
sampl
test
normal
distribut
dagostino
pearson
omnibu
normal
test
statist
analysi
normal
distribut
sampl
perform
use
anova
follow
bonferroni
posthoc
test
sampl
normal
distribut
analys
kruskalw
test
follow
dunn
multipl
comparison
test
mannwhitney
u
test
use
comparison
two
popul
data
analysi
perform
use
prism
softwar
graphpad
softwar
la
jolla
ca
statist
analys
p
valu
consid
signific
p
p
p
pneumonia
serotyp
variabl
haemolyt
activ
differenti
stimul
product
human
cell
confirm
product
human
cell
depend
pli
convent
inflammasom
infect
human
pbmc
pneumonia
serotyp
express
haemolyt
allel
pli
isogen
mutant
lack
pli
test
effect
inhibitor
found
pneumonia
express
pli
stimul
strong
product
wherea
plyneg
mutant
induc
small
amount
fig
contrast
transcript
regul
mrna
product
inflammasomeindepend
chemokin
affect
lack
pli
fig
moreov
secret
strongli
reduc
treatment
inhibitor
zyvad
fig
data
line
previous
publish
studi
show
pneumococc
pli
recogn
convent
inflammasom
stimul
product
next
investig
abil
differ
pneumococc
strain
induc
haemolysi
product
pneumonia
serotyp
induc
red
blood
cell
lysi
indic
express
haemolyt
pli
fig
contrast
serotyp
express
nonhaemolyt
pli
exhibit
haemolyt
activ
shown
fig
sequenc
pli
gene
confirm
express
allel
pli
serotyp
bacteria
demonstr
serotyp
express
haemolyt
allel
pli
tabl
allel
pli
possess
sever
mutat
protein
domain
fig
suggest
insert
host
cell
membran
conform
chang
therefor
crucial
poreform
abil
pli
accord
serotyp
stimul
strong
product
human
pbmc
wherea
serotyp
fig
unexpectedli
serotyp
also
rather
weak
induc
product
suggest
factor
pli
perhap
extens
capsul
product
serotyp
pneumococci
affect
innat
sens
bacteria
test
bacteria
induc
transcript
regul
mrna
fig
equal
stimul
product
inflammasomeindepend
chemokin
fig
moreov
cell
death
induc
pneumonia
depend
pli
fig
correl
express
haemolyt
pli
fig
accordingli
purifi
allel
pli
induc
much
stronger
cell
death
compar
allel
pli
human
cell
fig
collect
data
confirm
extend
previous
publish
result
demonstr
pneumococc
strain
express
divers
toxin
induc
differ
amount
product
cell
death
product
pneumoniaeinfect
human
lung
tissu
depend
pli
next
test
pneumoniaeinduc
product
human
lung
also
depend
pli
found
pneumonia
stimul
strong
product
human
lung
tissu
fig
contrast
strain
induc
express
mrna
protein
fig
inhibit
specif
inhibitor
zyvad
reduc
pneumococciinduc
product
il
tabl
pneumolysin
allel
determin
sequenc
pli
gene
perform
isol
use
studi
first
row
refer
amino
acid
posit
second
row
show
allel
pli
express
pneumonia
amino
acid
polymorph
clinic
isol
highlight
delet
amino
acid
repres
abbrevi
del
serotyp
pneumococci
express
allel
pli
previous
shown
fig
thu
product
pneumoniaeinfect
human
lung
tissu
depend
pli
inflammasom
infect
human
lung
tissu
differ
haemolyt
serotyp
nonhaemolyt
serotyp
pneumococc
strain
found
haemolyt
pneumonia
strain
significantli
induc
product
human
lung
wherea
nonhaemolyt
serotyp
bacteria
fig
accordingli
haemolyt
allel
pli
stimul
much
stronger
product
human
lung
compar
nonhaemolyt
allel
toxin
fig
data
indic
polymorph
pli
also
affect
product
human
lung
tissu
serotyp
bacteria
express
nonhaemolyt
pli
appear
evad
recognit
inflammasom
therefor
induc
littl
product
product
pneumoniaeinfect
human
lung
depend
final
test
product
pneumoniaeinfect
human
lung
tissu
depend
first
check
express
tissu
found
upregul
upon
pneumonia
infect
fig
second
treat
lung
tissu
inhibitor
glibenclamid
glibenclamid
block
potassium
channel
requir
inflammasom
activ
therefor
frequent
use
specif
inflammasom
inhibitor
found
inhibit
strongli
reduc
pneumoniaeinduc
product
fig
togeth
data
indic
inflammasom
mediat
product
upon
pneumonia
infect
detect
haemolyt
pli
human
lung
tissu
inflammasom
import
mediat
innat
immun
pneumococc
pneumonia
sens
pneumococc
pli
murin
macrophag
mediat
product
key
inflammatori
cytokin
accordingli
mice
defici
inflammasom
compon
receptor
show
alter
suscept
toward
pneumonia
although
rodent
particular
mice
wide
use
biomed
research
increas
evid
suggest
mechan
pathway
immun
system
differ
rodent
human
therefor
import
prove
relev
mechan
identifi
murin
model
humanrelev
system
studi
use
ex
vivo
explant
model
allow
investig
bacteri
viral
infect
human
lung
tissu
demonstr
detect
pli
inflammasom
also
critic
involv
product
human
lung
tissu
furthermor
variou
pneumococc
strain
express
natur
pli
variant
differenti
induc
inflammasomedepend
product
human
cell
lung
tissu
pli
major
virul
factor
pneumonia
exhibit
wide
varieti
activ
consist
virul
cytotox
host
cell
inhibit
ciliari
beat
respiratori
epithelium
activ
classic
complement
system
stimul
inflammasom
accordingli
bacteri
mutant
lack
pli
shown
rapidli
clear
lung
compar
wildtyp
bacteria
howev
less
clear
differ
activ
pli
contribut
pneumococc
virul
serotyp
clone
emerg
respons
serotyp
diseas
mani
part
world
associ
invas
pneumococc
diseas
outbreak
pneumococci
express
allel
pli
differ
amino
acid
haemolyt
allel
pli
lack
haemolyt
activ
retain
abil
bind
cholesterolcontain
membran
express
nonhaemolyt
pli
might
make
serotyp
bacteria
less
damag
harm
host
possibl
help
explain
serotyp
diseas
associ
lower
case
fatal
rate
compar
pneumococc
infect
howev
serotyp
pneumococci
carri
nonhaemolyt
pli
studi
clearli
requir
prove
disprov
hypothesi
recent
studi
compar
isogen
mutant
background
show
mutant
express
allel
pli
exhibit
mediumlevel
virul
compar
bacteria
express
haemolyt
pli
lack
toxin
express
taken
fact
togeth
epidemiolog
data
might
indic
cytolyt
activ
essenti
characterist
pneumococci
virul
noncytolyt
properti
pli
least
similarli
import
moreov
differ
activ
pli
might
even
less
essenti
secondari
pneumococc
pneumonia
follow
influenza
viru
infect
suggest
serotyp
might
actual
take
advantag
express
nonhaemolyt
toxin
variant
express
allel
pli
enabl
serotyp
pneumococci
avoid
detect
inflammasom
minim
product
key
proinflammatori
cytokin
specul
evas
inflammasomedepend
detect
serotyp
contribut
abil
invad
steril
compart
note
express
haemolyt
pli
addit
shown
requir
detect
pneumococc
peptidoglycan
dna
sting
depend
pathway
respect
avoid
recognit
pathway
might
thu
also
add
rel
particular
serotyp
pneumococci
potenti
line
assumpt
serotyp
pneumococci
appear
weak
induc
mrna
fig
moreov
like
plyindepend
characterist
strain
eg
capsul
cell
wall
composit
influenc
interact
innat
immun
system
exampl
recent
show
serotyp
bacteria
differ
serotyp
bind
ctype
lectin
receptor
mincl
taken
togeth
demonstr
differ
pneumococc
serotyp
differenti
activ
inflammasom
human
lung
tissu
import
serotyp
clone
evad
recognit
central
innat
immun
sens
mechan
import
dissect
contribut
innat
immun
evas
pathogen
potenti
global
emerg
bacteri
strain
